#Diabetes management :
💡keep BGL at normal levels
💡high BGL cause negative side effects:
🚫 blindness
🚫 loss of limbs
🚫 kidney failure
🚫 neuropathy
💡CHO raises BGL
#FROMPHARMACY
💡keep BGL at normal levels
💡high BGL cause negative side effects:
🚫 blindness
🚫 loss of limbs
🚫 kidney failure
🚫 neuropathy
💡CHO raises BGL
#FROMPHARMACY
#Metformin
💊Biguanide
💡MOA:
📎 reduce glu production in liver
📎 reduce absorption of glu
📎 Inc. Insulin sensitivity
💊1st line
💊cheap
🚫Not used with renal patients
#diabetes
#FromPharmacy
💊Biguanide
💡MOA:
📎 reduce glu production in liver
📎 reduce absorption of glu
📎 Inc. Insulin sensitivity
💊1st line
💊cheap
🚫Not used with renal patients
#diabetes
#FromPharmacy
#Sulfonylureas
🎈glipizide
🎈glyburide
🎈glimepiride
💡MOA:
📎increase the secretion of insulin by the pancreas
💊Taken before meal (cause insulin production)
💊cheap
💊ADR : HYPOGLYCEMIA
#diabetes
#FromPharmacy
🎈glipizide
🎈glyburide
🎈glimepiride
💡MOA:
📎increase the secretion of insulin by the pancreas
💊Taken before meal (cause insulin production)
💊cheap
💊ADR : HYPOGLYCEMIA
#diabetes
#FromPharmacy
#thiazolidediones TZD
🎈pioglitazone
💡MOA:
📎Dec. Insulin resistance
🚫 Not used with heart patients
#diabetes
#FromPharmacy
🎈pioglitazone
💡MOA:
📎Dec. Insulin resistance
🚫 Not used with heart patients
#diabetes
#FromPharmacy
#DPP4
🎈sitagliptin
🎈saxagliptin
🎈linagliptin
💡MOA:
📎Inhibits glucose release
📎decrease gastric emptying
📎increase insulin secretion
💊Frequently available as combination products.
🚫expensive
🚫may cause joint pain and sever disability.
#diabetes
#FromPharmacy
🎈sitagliptin
🎈saxagliptin
🎈linagliptin
💡MOA:
📎Inhibits glucose release
📎decrease gastric emptying
📎increase insulin secretion
💊Frequently available as combination products.
🚫expensive
🚫may cause joint pain and sever disability.
#diabetes
#FromPharmacy
#SGLT2
🎈canagliflozin
🎈empagliflozin
🎈dapagliflozin
💡MOA :
📎 reducing renal glu. reabsorption
📎 reduction in BGL without stimulating insulin release.
🚫expensive
🚫 may cause UTI
🚫 NOT used renal patients
#diabetes
#FromPharmacy
🎈canagliflozin
🎈empagliflozin
🎈dapagliflozin
💡MOA :
📎 reducing renal glu. reabsorption
📎 reduction in BGL without stimulating insulin release.
🚫expensive
🚫 may cause UTI
🚫 NOT used renal patients
#diabetes
#FromPharmacy
Loading suggestions...